AD-HOC

Mountain Alliance AG passes resolution on executing an ordinary capital increase

Mountain Alliance AG, Munich (ISIN: DE000A12UK08), hereby announces that the Executive Board decided on 3 July 2019, with approval from the Supervisory Board on the same day, to execute the ordinary capital increase against cash contribution, as resolved by the Annual General Meeting, from EUR 6,045,720.00 by up to EUR 3,022,860.00 to up to EUR 9,068,580.00 by issuing […]

Read More
Mountain Alliance AG: Resolution of the Management Board on the proposal to the Annual General Meeting regarding a capital increase with subscription rights

[et_pb_section bb_built="1"][et_pb_row][et_pb_column type="4_4"][et_pb_text] The Management Board of the Company has decided to propose to the 2019 Annual General Meeting a resolution on a capital increase with subscription rights and has commissioned MainFirst Bank AG to support the intended capital increase. The amount of the increase and the amount at which the new shares will be […]

Read More
Mountain Alliance AG: Group result 2018 impacted by share price development of the portfolio company The Native SA

Mountain Alliance AG, according to preliminary calculations, is expected to report earnings before taxes (EBT) of approximately TEUR minus 1,800 for the 2018 financial year (previous year: TEUR 670). While the previous forecast of the Management Board provided an annual result for 2018, which was assumed to continue without taking exits into account on the […]

Read More

Company News

Mountain Alliance AG: Portfolio company Qwello attracts Tiger Infrastructure Partners as new investor

Charging infrastructure start-up Qwello, a portfolio company of Mountain Alliance AG (MA, ISIN DE000A12UK08), has attracted a new investor with US-based private equity firm Tiger Infrastructure Partners. Tiger Infrastructure Partners invests EUR 50 million in Qwello with the objective of creating a leading provider of charging infrastructure for electric vehicles. Mountain Alliance AG holds approximately 2% of […]

Read More
Mountain Alliance AG publishes Half-Year Report 2021 – Net Asset Value per Share increases to EUR 7.67

Portfolio value rising to EUR 54.8 million after EUR 50.8 million as of 31 December 2020 Net asset value (NAV) improved by 11% to EUR 52.8 million (31 December 2020: EUR 47.8 million) NAV per share at EUR 7.67 as of 30 June 2021 High demand for digital business models   Munich, 21 September 2021 – Mountain Alliance AG (MA, […]

Read More
Mountain Alliance AG: Board re-sizing – Daniel Wild leaves management board to join supervisory board

Munich, 17. May 2021 – Daniel Wild, Chairman of the Management Board of Mountain Alliance AG (ISIN DE000A12UK08), will leave his position at the end of the annual general meeting on 30 June 2021 as part of the further optimisation of board sizes, and is to move up to a down-scaled Supervisory Board in the […]

Read More

Portfolio News

Exasol is named “Overall Data Analytics Company of the Year”

25.03.2021 - Analytics database provider Exasol has been named winner of the “Overall Data Analytics Company of the Year” category at the 2021 Data Breakthrough Awards. The independent market analyst Data Breakthrough recognizes outstanding companies, technologies, and products in the global data technology market with the awards. Exasol was able to win an award at […]

Read More
Qwello CEO Henrik Thiele on the current development of electromobility in Germany

23.03.2021 - The expansion of electromobility is one of the most important mobility and infrastructure developments of our time. In 2020 alone, the number of cars with electric drives in Germany doubled due to 40,000 new registrations. The increase is continuing. The rapid expansion of an efficient charging infrastructure is crucial for the attractiveness of […]

Read More
Bio-Gate CEO Marc Lloret-Grau reports on the successful cooperation with clinics in the field of innovative medical products in newspaper F.A.Z.

March 2021 - When implants and prostheses are used surgically, there is always a high risk of infection for the patient. Bio-Gate has developed the antiviral and antimicrobial implant coating “HyProtect” especially for this area. It is already being used with great success at the Regensburg University Hospital. Bio-Gate and the clinic have been cooperating […]

Read More

Press

linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram